Prevalence and Prognostic Implications of Bundle Branch Block in Comatose Survivors of Out-of-Hospital Cardiac Arrest - 12/10/16
, Jesper Kjaergaard, MD, PhD, DMSc a, Niklas Nielsen, MD, PhD b, David Erlinge, MD, PhD c, Sebastian Wiberg, MD a, Michael Wanscher, MD, PhD d, John Bro-Jeppesen, MD, PhD a, Christian Hassager, MD, DMSc aAbstract |
This study reports the prevalence and prognostic impact of right bundle branch block (RBBB) and left bundle branch block (LBBB) in the admission electrocardiogram (ECG) of comatose survivors of out-of-hospital cardiac arrest (OHCA). The present study is part of the predefined electrocardiographic substudy of the prospective randomized target temperature management trial, which found no benefit of targeting 33°C over 36°C in terms of outcome. Six-hundred eighty-two patients were included in the substudy. An admission ECG, which defined the present study population, was available in 602 patients (88%). These ECGs were stratified by the presence of LBBB, RBBB, or no-BBB (reference) on admission. End points were mortality and neurologic outcome 6 months after OHCA. RBBB was present in 79 patients (13%) and LBBB in 65 patients (11%), and the majority of BBBs (92%) had resolved 4 hours after admission. RBBB was associated with significantly higher 6 months mortality (RBBB: hazard ratio [HR]unadjusted 1.78, 95% confidence interval [CI] 1.30 to 2.43; LBBB: HRunadjusted 1.26, 95% CI 0.87 to 1.81), but this did not reach a level of significance in the adjusted model (HRadjusted 1.33, 95% CI 0.94 to 1.87). Similar findings were seen for neurologic outcome in the unadjusted and adjusted analyses. RBBB was further independently associated with higher odds of unfavorable neurologic outcome (RBBB: adjusted odds ratio 1.97, 95% CI 1.05 to 3.71). In conclusion, BBBs after OHCA were transient in most patients, and RBBB was directly associated with higher mortality and independently associated with higher odds of unfavorable neurologic outcome. RBBB is seemingly an early indicator of an unfavorable prognosis after OHCA.
Le texte complet de cet article est disponible en PDF.Plan
| The TTM trial was supported by independent research grants from the Swedish Heart-Lung Foundation (Sweden) (grant nos: 20090275, 20120491), Arbetsmarknadens Försäkringsaktiebolag (Sweden) (grant no: 100001), Insurance Foundation (Sweden), Swedish Research Council (Sweden) (grant no: 2013/3572), Region Skåne (Sweden) (grant nos: 60251, 134241, 286321, 452021), National Health Service (Sweden), Thelma Zoega Foundation (Sweden), Krapperup Foundation (Sweden), Thure Carlsson Foundation (Sweden), Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research (Sweden), Skåne University Hospital (Sweden), TrygFonden (Denmark) (grant no: 7-12-0454), and European Clinical Research Infrastructures Network (France). The electrocardiographic substudy was supported by the Interreg IVA ØKS program supported as part of the grant for establishing the Center for Resuscitation Science in the Oresund Region (NYPS ID: 167157), with regard to authors Thomsen, Hassager, and Kjaergaard. The Danish Heart Foundation (Denmark) supported the study as part of a grant for co-funding of the Centre for Resuscitation Science in the Oresund Region (as mentioned earlier; grant no: 13-04-R94-A4516-22755). The Danish Heart Foundation (grant nos 13-04-R94-A4460-22756 and 14-R97-A5142-22831) has supported this study with salary in Dr. Thomsen's PhD project. The Foundation of Brødrene Hartmann supported this study with equipment for ECG recordings. |
|
| See page 1199 for disclosure information. |
Vol 118 - N° 8
P. 1194-1200 - octobre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
